Cellid Co (XKRX:299660) Short-Term Debt : ₩5,497.27 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Cellid Co Short-Term Debt?

Cellid Co's Short-Term Debt for the quarter that ended in Dec. 2023 was ₩5,497.27 Mil.

Cellid Co's quarterly Short-Term Debt increased from Jun. 2023 (₩7,661.41 Mil) to Sep. 2023 (₩7,946.86 Mil) but then declined from Sep. 2023 (₩7,946.86 Mil) to Dec. 2023 (₩5,497.27 Mil).

Cellid Co's annual Short-Term Debt increased from Dec. 2021 (₩0.00 Mil) to Dec. 2022 (₩11,875.37 Mil) but then declined from Dec. 2022 (₩11,875.37 Mil) to Dec. 2023 (₩5,497.27 Mil).

Cellid Co Short-Term Debt Historical Data

The historical data trend for Cellid Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellid Co Short-Term Debt Chart

Cellid Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

11,875.37

5,497.27

Cellid Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															11,875.37	7,389.55	7,661.41	7,946.86	5,497.27

Cellid Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Cellid Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Cellid Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Cellid Co (XKRX:299660) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellid Co Ltd (XKRX:299660) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Gwanak-ro, Gwanak-gu, 142 Suite 504, Korea Seoul National University Building, seoul, KOR, 08826

Website

http://www.cellid.co.kr

Cellid Co Ltd is a research and development bioventure company. The company is developing immunotherapeutic vaccines, CeliVax. The CeliVax is a personalized vaccine which uses patient's own cells.

Cellid Co (XKRX:299660) Headlines

No Headlines